Rubrik (NYSE: RBRK) expands AI cybersecurity alliance as Code Guardian enters enterprise delivery push
Read More Pharma Industry News UK fast-tracks clinical trials with 14-day reviews and AI simulation support to regain R&D edge Find out how MHRA’s 2026 trial reforms—fast-track routes, AI models, and 14-day reviews—aim to make the UK a global leader in clinical research again. bySrinathJanuary 13, 2026